Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma

NCT02630030 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Ixazomib

Sponsor

Emory University

Collaborators

[object Object]